» Articles » PMID: 4611528

Enzyme Replacement in Pompe Disease: an Attempt with Purified Human Acid Alpha-glucosidase

Overview
Date 1973 Mar 1
PMID 4611528
Citations 11
Authors
Affiliations
Soon will be listed here.
Citing Articles

Advancing the Research and Development of Enzyme Replacement Therapies for Lysosomal Storage Diseases.

Puhl A, Ekins S GEN Biotechnol. 2022; 1(2):156-162.

PMID: 35706761 PMC: 9192161. DOI: 10.1089/genbio.2021.0013.


Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.

Macauley S Pediatr Endocrinol Rev. 2016; 13 Suppl 1:639-48.

PMID: 27491211 PMC: 5374980.


Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases.

Oh D BMB Rep. 2015; 48(8):438-44.

PMID: 25999178 PMC: 4576951. DOI: 10.5483/bmbrep.2015.48.8.101.


The respiratory neuromuscular system in Pompe disease.

Fuller D, Elmallah M, Smith B, Corti M, Lawson L, Falk D Respir Physiol Neurobiol. 2013; 189(2):241-9.

PMID: 23797185 PMC: 4083814. DOI: 10.1016/j.resp.2013.06.007.


Consensus treatment recommendations for late-onset Pompe disease.

Cupler E, Berger K, Leshner R, Wolfe G, Han J, Barohn R Muscle Nerve. 2011; 45(3):319-33.

PMID: 22173792 PMC: 3534745. DOI: 10.1002/mus.22329.